Venetoclax-based regimens in combination with trametinib for RAS-mutated relapsed or refractory myeloid malignancies

Venetoclax-based regimens in combination with trametinib for RAS-mutated relapsed or refractory myeloid malignancies

Saved in:
Bibliographic Details
Published in:Bone marrow transplantation (Basingstoke) Vol. 57; no. 6; pp. 1034 - 1037
Main Authors: Kevlicius, Lukas, Cepulyte, Ruta, Vasilevska, Dominika, Griskevicius, Laimonas, Zucenka, Andrius
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 01-06-2022
Nature Publishing Group
Subjects:
38/77
45/23
631/67/1059/602
692/699/1541/1990/283/1897
96
96/31
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Bridged Bicyclo Compounds, Heterocyclic - pharmacology
Bridged Bicyclo Compounds, Heterocyclic - therapeutic use
Cell Biology
Correspondence
Hematology
Humans
Internal Medicine
Leukemia, Myeloid, Acute - drug therapy
Medicine
Medicine & Public Health
Neoplasm Recurrence, Local - drug therapy
Public Health
Pyridones
Pyrimidinones - pharmacology
Pyrimidinones - therapeutic use
Stem Cells
Sulfonamides
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:content type line 23
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ISSN:0268-3369
1476-5365
1476-5365
DOI:10.1038/s41409-022-01679-6